June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Effect of Doxycycline on Retinal Ganglion Cells in an Experimental Glaucoma Model
Author Affiliations & Notes
  • Tae-eun Lee
    Ophthalmology, Chonbuk National University, Jeonju-si, Jeollabuk-do , Korea (the Republic of)
    Ophthalmology, Korea University, Seoul, Korea (the Republic of)
  • Yong Yeon Kim
    Ophthalmology, Korea University, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Tae-eun Lee, None; Yong Yeon Kim, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2572. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Tae-eun Lee, Yong Yeon Kim; Effect of Doxycycline on Retinal Ganglion Cells in an Experimental Glaucoma Model. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2572.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the effect of doxycycline on the death of retinal ganglion cells (RGCs) and impacting matrix metalloproteinase (MMP) expression in an experimental model of glaucoma.

Methods : The glaucomatous experimental model was induced by cauterizing vortex and episcleral veins in the eyes of 36 rabbits. The effects of oral doxycycline administration at dosages of 10 mg/kg/day (n=12) and 30 mg/kg/day (n=12) were evaluated and compared with the untreated controls (n=12). The eyes were histologically examined for RGC death at two and four weeks. The expression and activity of MMP-2 and MMP-9 were measured by immunohistochemical analysis and gelatin zymography.

Results : When compared to the baseline value the intraocular pressure of the operated eyes was significantly elevated at each time point. Significantly denser RGCs were found in the retinal ganglion cell layer and lower rates of apoptosis were observed in the high dose treatment (30 mg/kg/day) group, as compared to the control group at two and four weeks after treatment, whereas in the low dose
treatment (10 mg/kg/day) group, such change was observed only at two weeks post-treatment. The expressions and the gelatinolytic activity of MMP-2 and MMP-9 were significantly suppressed in the doxycycline treatment group at two and four weeks.

Conclusions : The result of this study suggests that doxycycline could contribute to delaying the death of RGCs through the down-regulation of MMPs, at least in part, in this experimental model of glaucoma.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×